TerminatedPhase 3NCT00395538
Effects of PTH Replacement on Bone in Hypoparathyroidism
Studying 22q11.2 deletion syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Principal Investigator
- Rachel I Gafni, M.D., MDNational Institute of Dental and Craniofacial Research (NIDCR)
- Intervention
- PTH 1-34(drug)
- Enrollment
- 46 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2006 – 2017
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00395538 on ClinicalTrials.govOther trials for 22q11.2 deletion syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05664412Using Transcranial Alternating Current Stimulation to Improve Executive Function in 22q11.2 Deletion SyndromeStephan Eliez
- RECRUITINGNCT05924347Early Scoliotic Changes in Children at Increased Risk for Scoliosis DevelopmentUMC Utrecht
- RECRUITINGNCT05329935Congenital Athymia Patient RegistrySumitomo Pharma Switzerland GmbH
- RECRUITINGNANCT04639388Understanding of Psychotic Disorders in Children With 22q11.2DSHôpital le Vinatier
- RECRUITINGNCT00556530Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion SyndromeAlbert Einstein College of Medicine